Homogenates of normal rat tissues inhibited several functional parameters of normal human peripheral blood leukocytes, including luminol-dependent chemiluminescence induced by both soluble (phorbol myristate acetate) and particulate (Escherichia coli) stimuli; in vitro uptake of radiolabeled E. coli; and in vitro phagocytosis and killing of E. coli. The doses of rat tissue protein that caused a 50% inhibition of leukocyte chemiluminescence were ca. 6.2 ,ug for small intestine, 83 jig for kidney; 100 ,ug for heart; 132 ,ug for liver, 190 ,ug for skeletal muscle, and 307 ,ug for brain. The putative phagocytosis inhibitor (PI) in rat liver was more plentiful in particulate fractions than in the cytosol. The PI activity in the original or Miranol-solubilized rat liver homogenate was nondialyzable, and it was reduced substantially by heating at 90°C for 30 min but not at 56°C for 30 min. It was unaffected by aprotinin, a potent inhibitor of proteolytic activity. Treatment of tissues with trypsin did not reduce PI activity, whereas treatment with phospholipase A2 clearly increased it. The bulk (up to 88%) of PI in rat liver or small intestine could be extracted by lipid solvents, e.g., diethyl ether. Purified fatty acids were potent inhibitors of leukocyte chemiluminescence; other lipids had little or no inhibiting activity. The various data suggest that (i) normal tissues contain a potent PI and (ii) that the PI is a lipid moiety.
systemic illness. Our studies showed the presence of a potent inhibitor of leukocyte function in tissue fractions and diethyl ether extracts of tissues. We studied ether extracts of tissues because pilot studies had suggested that the tissue leukocyte inhibitor is a lipid. The tissue inhibitor affected leukocyte activity not only when leukocytes were activated by a common pathogen, Escherichia coli, but also by a soluble stimulus, i.e., phorbol myristate acetate. The latter data suggested that tissue phagocytosis inhibitor (PI) may act at least in part by influencing oxidative metabolism in the leukocytes.
MATERIALS AND METHODS Tissue homogenates. Fresh tissues obtained from male Sprague-Dawley rats were homogenized in 3 volumes of 0.15 M phosphate buffer (pH 7.4) by using a Polytron homogenizer (Brinkman Instruments, Westbury, N.Y.). Homogenates were filtered through four layers of gauze. The protein concentrations of the homogenates were measured by the method of Bradford (4) , using kits available commercially from Bio-Rad Laboratories (Richmond, Calif.). For some studies, human tissues were used; they were obtained at the time of autopsy from patients who had died from noninfectious systemic disorders.
Subcellular fractions. Subcellular fractions were prepared by ultracentrifugation of tissues homogenized in 0.25 M sucrose, as described by Schneider and Hogeboom (10) .
Bacteria. E. coli Ojo0KN was a blood culture isolate * Corresponding author.
obtained from the Infectious Diseases Laboratories at the UCLA Department of Medicine. The bacteria were grown overnight at 37°C in brain heart infusion broth. Pilot studies had indicated that these organisms are resistant to pooled normal human serum in concentrations up to 50% (14) . The bacteria were washed twice with physiological (0.9%) saline and brought to a concentration of 108 organisms per ml of buffer.
Leukocytes. Venous blood was obtained by venipuncture of normal healthy volunteers with a plastic syringe containing heparin (10 U/ml of blood). Leukocytes were separated from erythrocytes by dextran sedimentation as described originally by Boyum (3) . Five volumes of blood were mixed with 1 part 6% dextran (500,000 molecular weight) in saline to facilitate clumping and sedimentation of erythrocytes.
After sedimentation for 35 min at room temperature, the leukocyte-rich supernatant was carefully removed and centrifuged at 270 x g for 10 min.
The pellet of leukocytes was washed with cold 0.1% glucose in saline. It was exposed to cold hypotonic (0.22%) saline for 30 s to lyse contaminating erythrocytes followed by addition of an equal volume of 1.54% saline to restore the cell suspension to isotonicity. Hypotonic hemolysis was repeated once. Leukocytes were finally suspended (2 x 105 per ml) in Hanks buffer (8) .
Purification of PMNs. Mono-poly resolving medium was purchased from Flow Laboratories Inc., Inglewood, Calif. Fresh, heparinized normal human blood (3.5 ml) was layered on the top of 3 ml of mono-poly resolving medium in a sterile test tube (13 by 100 mm) and centrifuged at 300 x g at room temperature for 30 min. After the top layer of plasma was removed, the band of polymorphonuclear leukocyte (PMN)-rich cells was drawn off with a clean Pasteur pipette and placed into a tube containing 10 rat small intestine, liver, kidney, skeletal muscle, and I inhibited CL in a dose-dependent manner. The amoui tissue protein that caused a half-maximal inhibition o0 was about 6.2 pLg for small intestine, 83 pLg for kidney, 1( for heart, 132 ,ug for liver, 190 p.g for skeletal muscle. 307 p.g for brain (Fig. 1) . Similar data were obtaine another experiment with autopsy specimens of human and kidney.
Evidence against nonspecific inhibition of CL by tis The role of possible methodological artifacts in the inhib of CL by tissue homogenates was considered. First examined whether the presence of tissue fractions not cifically interfered with the light emitted by oxidized lur in a cell free system. Luminol was incubated with hors ish perioxidase and H202 (12) Effect of PI on phagocytosis of radiolabeled E. coli. To examine further the possible presence of a PI activity in the tissues, we evaluated the effect of rat liver fractions on leukocyte phagocytosis of [inethl_/-3H]thymidine-labeled bacteria. There was a dose-dependent inhibition of phagocytosis in the presence of tissue fractions (Fig. 3) .
Effect of PI on in vitro killing of E. coli by leukocytes. We employed an in vitro assay for "killing" of bacteria by leukocytes. There was again a clear inhibition of leukocyte killing of E. (coli in the presence of rat small intestine homogenate (Fig. 4) (Fig. 5) . It has been shown that the majority of the PI activity of rat liver microsomes can be solubilized with 0.5% Miranol H2M (Miranol Chemical Co., N.J.) (9) Table 1 ). There was also a reduction in CL when microsomes were incubated with E. (coli during opsonization with serum followed by sedimentation of bacteria before addition of leukocytes (group IV, Table 1 ). However, the effect of microsomes on opsonization of E. coli was much less than the effect on leukocytes (group IV versus group III. Table 1) .
Physiochemical characteristics of PI. Human and rat liver homogenates were dialyzed against 100 volumes of distilled water at 4°C for 24 h with one change. There was no reduction in PI activity in the dialyzed homogenate: there was actually some increase in the PI activity of the dialyzed human liver homogenate (Fig. 6 ).
PI activity in rat tissue homogenates was tested for heat lability during heating at 90°C for 30 min and at 56WC for 30 min. Leukocytes were preincubated with heated or control tissue homogenates before incubation with opsonized E. coli. Heating of the tissues at 90°C for 30 min was associated with a marked reduction in PI activity. Heating at 560C for 30 min had no effect.
PI activity in Miranol-solubilized rat liver homogenate was precipitated by 1.6 M ammonium sulfate or 2% boric acid (20 volumes, pH 4.5) (Fig. 6 ). There was some loss of PI activity after treatment with ammonium sulfate. However, a majority of the activity recovered was in the precipitate rather than in the supernatant. In the case of boric acid precipitation, PI was demonstrable in the supernatant, although at a concentration substantially less than that in the precipitate or in the starting homogenate.
Effect of repeated freezing and thawing. Effect of storage at room temperature. Figure 7 shows the data on changes in PI activity during storage of portions of tissue homogenates at room temperature (22°C). Portions of fresh tissue homogenates were incubated at room temperature and then frozen at -10°C until 72 h when the experiment was completed. There was a progressive increase in PI activity of the tissue with the passage of time. The amount of tissue protein that caused a 50% inhibition of leukocyte CL was 116 ,ug for fresh rat liver homogenate, and 31, 16, 13, and 4.7 ,Lg for samples stored at room temperature for 8, 24, 48, and 72 h, respectively (Fig. 7) .
PI activity in extracts of rat liver homogenate. We examined the extractability of tissue PI activity in several lipid solvents, including chloroform-methanol, ether, and ethanol. Based on the doses (milligram-equivalents) that caused a 50% inhibition of leukocyte luminol-dependent CL, evaporated ether extract of solubilized rat liver homogenate was about 88% as potent as starting homogenate. Similarly, evaporated choloroform-methanol and ethanol extracts contained ca. 60% (60 and 58%, respectively) of the PI activity of liver homogenate.
Anticomplementary activity of tissue homogenate and tissue extracts. The dose of rat liver homogenate protein that reduced E. coli-induced PMN CL by 50% (270 p.g) caused a 30% reduction in complement activity in the Quantiplate assay. However, a similarly inhibitory dose of rat small intestine protein (8 jig) did not demonstrate any anticomplementary activity. Evaporated ether extracts of both small intestine homogenate and liver homogenate had no detectable anticomplementary activity in doses up to threefold greater than those causing a 50% inhibition of E. colistimulated CL. These data suggest that the PI activity of the tissues is not due to their anticomplementary activity.
Effect of treatment with trypsin on tissue PI activity. Based on the doses that caused a 50% inhibition of E. colistimulated leukocyte CL, there was no effect of trypsin treatment on the PI activity of rat small intestine homogenate or rat liver homogenate. The dose that caused a 50% inhibition of leukocyte CL was 0.15 mg-eq (wet weight of tissue) for small intestine and 0.66 mg-eq for liver before trypsin treatment and 0.17 mg-eq for small intestine and 0.5 mg-eq for liver after treatment of the tissue with trypsin. Effect of treatment with PLA2 on tissue PI activity. Incubation of rat liver homogenate with PLA2 was associated with a marked (about 10-fold) enhancement of its PI activity. Thus, the dose of tissue that caused a 50% inhibition of E. colistimulated leukocyte luminol-dependent CL was 0.5 mg-eq (wet weight tissue) in controls and 0.04 mg-eq after PLA2 treatment. There was a similar but less marked stimulation of PI activity of the small intestine homogenate after treatment with PLA2; the doses of tissue that caused a 50% inhibition of leukocyte CL were 0.23 mg-eq (wet weight of tissue) in controls and 0.16 mg-eq after PLA2 treatment.
Reversibility of inhibitory effect of tissue homogenates on leukocytes. Since the above-mentioned studies suggested that the PI activity of tissues may be a lipid moiety and since HSA binds fatty acids, we tested whether HSA would reverse the inhibition effect of tissue extracts on the leukocytes (Table 3 ). It was evident that HSA inhibits the PI activity of rat liver homogenate or ether extract of rat liver homogenate and that leukocytes can recover from the effects of the tissue factor.
Effect of various lipids on E. coli-stimulated leukocyte luminol-dependent CL. Figure 8 shows (1, 13) , by uptake of [methyl-3H]thymidine-labeled bacteria. (15, 16) , or by in vitro killing of bacteria by leukocytes (13) . The inhibitory activity was also demonstrated when fractionated PMNs were used in place of mixed leukocytes. These data suggest that the observed PI effect is probably not a result of the effect of tissue components on cells other than PMNs. Since the luminol CL assay is the most practical assay, it was used for the majority of our studies. Our studies indicate that inhibition of CL by tissues is not a result of quenching of light emmitted by activated luminol by tissue fractions (Fig. 2) Our data suggest that tissue fractions inhibit the attachment or ingestion (or both) of E. coli by PMNs (Fig. 3) . This effect of tissue fractions may also contribute to their inhibitory effect on E. coli-induced CL (Fig. 1) and on intracellular killing of E. coli (Fig. 4) . We found that tissue fractions had little or no CL-inhibiting effect once the phagocytosisassociated CL was initiated (Fig. 2) . These data suggest that tissue fractions exert their effect on early steps of phagocytosis, possibly those related to adhesion, uptake, or ingestion of bacteria by PMNs. Clearly, further study is needed to determine the mechanism of action of PI and to determine whether tissue fractions exert a direct effect on intracellular killing of E. coli by PMNs.
It is of interest to consider possible functions of PI in various tissues. One may speculate that it has a role in preventing activation of PMN phagocytosis during their normal circulation through the tissues. Under circumstances wherein integrity of tissue membranes is damaged, as occurs in many severe illnesses (17) , it is conceivable that tissue elements responsible for PI activity leak out into the blood and limit the phagocytic ability of PMNs, thus causing the reduction in resistance to infection that is common in such illnesses. Further studies are clearly needed to strengthen or refute this possibility. In the meantime, it is interesting to recall that a thyroid hormone binding inhibitor, which like PI is normally present in tissues or ether extracts of tissues (5, 6) , is detectable in sera of patients with a variety of severe systemic illnesses (5) . It is also important to note that evidence is becoming strong that the thyroid hormone binding inhibitor is a fatty acid (5) .
